Want to join the conversation?
For 4Q15, $FEYE expects total revenue to be in the range of $182-190MM. On a non-GAAP basis, the company expects total billings to be $240-260MM. Net loss was expected to be between $0.36-0.38 per share, based on estimated weighted average shares outstanding of about 156MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)